Remove tag virtual-meetings
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

There is agreement that trials need to meet the people, at home and covering clinical trial deserts. Consider secure digital identification, two-fact authentication or virtual/video visits. Balance with not adding barriers for participation. The skills may also vary between trials and getting participants the care they need.

article thumbnail

Johnson & Johnson to Participate in Bernstein’s 37th Annual Strategic Decisions Virtual Conference

The Pharma Data

Johnson & Johnson to Participate in Bernstein’s 37th Annual Strategic Decisions Virtual Conference | Johnson & Johnson. Johnson & Johnson Statement on April 23 CDC Advisory Committee Meeting. Johnson & Johnson to Participate in Bernstein’s 37th Annual Strategic Decisions Virtual Conference. Skip to content.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Rethinking Clinical Trials

The work started before COVID-19, and the idea was to meet every six months. We had an opportunity to meet once, and then everything became virtual. We also included multiple meetings with our academic stakeholders. One important note is that we specifically moved away from a checklist approach.

article thumbnail

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Rethinking Clinical Trials

The work started before COVID-19, and the idea was to meet every six months. We had an opportunity to meet once, and then everything became virtual. We also included multiple meetings with our academic stakeholders. One important note is that we specifically moved away from a checklist approach.

article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Before, there would have been 12 people in a meeting room with a notepad. “We’re

article thumbnail

A roadmap for adopting New Science 

pharmaphorum

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. And 65% of pharma sales rep meetings were held virtually.

article thumbnail

Insights From Medical Affairs Interactions

pharmaphorum

Whether it’s a discussion at an advisory board or an interaction at a (virtual) congress, the end result is still a plethora of valuable insights. We are all familiar with the valuable insights that MSLs bring in from the field. But what about insights from Medical Affairs interactions?

52